These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 35024696)

  • 1. Androgens and Parkinson's Disease: A Review of Human Studies and Animal Models.
    Bourque M; Soulet D; Di Paolo T
    Androg Clin Res Ther; 2021; 2(1):294-303. PubMed ID: 35024696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Androgens and Parkinson's disease: the role in humans and in experiment].
    Hamadyanova AU; Kuznetsov KO; Gaifullina EI; Kalandin DA; Khamidullina RR; Khalitova IF; Faizov RM; Kamaletdinova NO; Aslanova BF; Nakieva AG; Burangulova LE; Gaisina GO
    Probl Endokrinol (Mosk); 2022 Sep; 68(6):146-156. PubMed ID: 36689720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing sex steroids and related drugs as potential treatment for Parkinson's disease.
    Bourque M; Morissette M; Di Paolo T
    Neuropharmacology; 2019 Mar; 147():37-54. PubMed ID: 29649433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective and neurotoxic outcomes of androgens and estrogens in an oxidative stress environment.
    Duong P; Tenkorang MAA; Trieu J; McCuiston C; Rybalchenko N; Cunningham RL
    Biol Sex Differ; 2020 Mar; 11(1):12. PubMed ID: 32223745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroactive steroids and Parkinson's disease: Review of human and animal studies.
    Bourque M; Morissette M; Di Paolo T
    Neurosci Biobehav Rev; 2024 Jan; 156():105479. PubMed ID: 38007170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of pharmaceutical compounds on male fertility.
    Neumann F; Diallo FA; Hasan SH; Schenck B; Traore I
    Andrologia; 1976; 8(3):203-35. PubMed ID: 793446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgens and cardiovascular disease.
    Liu PY; Death AK; Handelsman DJ
    Endocr Rev; 2003 Jun; 24(3):313-40. PubMed ID: 12788802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin influences upon androgen action in male accessory sex organs.
    Thomas JA; Keenan EJ
    Adv Sex Horm Res; 1976; 2():425-70. PubMed ID: 189591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease.
    Gillies GE; Murray HE; Dexter D; McArthur S
    Pharmacol Biochem Behav; 2004 Jul; 78(3):513-22. PubMed ID: 15251260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum androgen bioactivity during 5alpha-dihydrotestosterone treatment in elderly men.
    Raivio T; Tapanainen JS; Kunelius P; Jänne OA
    J Androl; 2002; 23(6):919-21. PubMed ID: 12399539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in androgens during treatment with four low-dose contraceptives.
    Coenen CM; Thomas CM; Borm GF; Hollanders JM; Rolland R
    Contraception; 1996 Mar; 53(3):171-6. PubMed ID: 8689882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females.
    Murray HE; Pillai AV; McArthur SR; Razvi N; Datla KP; Dexter DT; Gillies GE
    Neuroscience; 2003; 116(1):213-22. PubMed ID: 12535954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in Parkinson's disease and other movement disorders.
    Smith KM; Dahodwala N
    Exp Neurol; 2014 Sep; 259():44-56. PubMed ID: 24681088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen physiology: unsolved problems at the millennium.
    Wilson JD; Leihy MW; Shaw G; Renfree MB
    Mol Cell Endocrinol; 2002 Dec; 198(1-2):1-5. PubMed ID: 12573808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgens and estrogens in benign prostatic hyperplasia: past, present and future.
    Nicholson TM; Ricke WA
    Differentiation; 2011; 82(4-5):184-99. PubMed ID: 21620560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.
    Traish AM
    Adv Exp Med Biol; 2017; 1043():473-526. PubMed ID: 29224108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatoid arthritis, the contraceptive pill, and androgens.
    James WH
    Ann Rheum Dis; 1993 Jun; 52(6):470-4. PubMed ID: 8323402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes--androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5alpha-reduced androgens.
    Schmidt M; Weidler C; Naumann H; Anders S; Schölmerich J; Straub RH
    Arthritis Res Ther; 2005; 7(5):R938-48. PubMed ID: 16207335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen metabolite-dependent growth of hormone receptor-positive breast cancer as a possible aromatase inhibitor-resistance mechanism.
    Hanamura T; Niwa T; Nishikawa S; Konno H; Gohno T; Tazawa C; Kobayashi Y; Kurosumi M; Takei H; Yamaguchi Y; Ito K; Hayashi S
    Breast Cancer Res Treat; 2013 Jun; 139(3):731-40. PubMed ID: 23780684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Androgens in Female Genitourinary Tissue Structure and Function: Implications in the Genitourinary Syndrome of Menopause.
    Traish AM; Vignozzi L; Simon JA; Goldstein I; Kim NN
    Sex Med Rev; 2018 Oct; 6(4):558-571. PubMed ID: 29631981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.